Skip to main content

Real-world effectiveness of structured lifestyle interventions in preventing type 2 diabetes

Agency: Centers for Disease Control and Prevention - ERA

Assistance Listings
  • 93.068 -- Chronic Diseases: Research, Control, and Prevention

Archived opportunityLast Updated: May 13, 2026

View version history on Grants.gov

The purpose of this Notice of Funding Opportunity Announcement (NOFO) is to assess the long-term effectiveness, cost-effectiveness, and barriers to enrollment in or completion of structured lifestyle interventions (SLI), as implemented by the National Diabetes Prevention Program (NDPP). This NOFO has two (2) components to achieve the purpose of the program: Component A: To evaluate the long-term (≥5 years) effectiveness and cost-effectiveness of SLI participants, and identify barriers to participation and adherence in these SLI programs, overall and by age group, sex, race/ethnicity, and socio-economic...

Eligibility

Eligible applicants

Nonprofit

  • Nonprofits non-higher education without 501(c)(3)
  • Other Native American tribal organizations
  • Nonprofits non-higher education with 501(c)(3)

Business

  • Small businesses
  • For-profit organizations other than small businesses

Miscellaneous

  • Other
  • Unrestricted

Government

  • City or township governments
  • County governments
  • Special district governments
  • State governments
  • Public and Indian housing authorities
  • Federally recognized Native American tribal governments

Education

  • Independent school districts
  • Private institutions of higher education
  • Public and state institutions of higher education

Additional information

For an applicant to be even considered they must be responsive to the following. Component A - Longitudinal Cohort: Applicants must provide evidence of being able to access electronic records for building a cohort of individuals meeting eligibility criteria for the NDPP/MDPP (both participated in the NDPP/MDPP and not participated but eligible for the NDPP/MDPP program), individual program participation information of the NDPP/MDPP participants, medical records and health services utilization and cost data of all study participants. A minimum number of 5,000 NDPP/MDPP program enrollees and equal or a greater number of matched controls is required per applicant. If the application is incomplete or non-responsive to the special eligibility requirements listed in this section, it will not enter into the review process. Component B - Coordinating Center: Not Applicable

Grantor contact information

Description

Dionne Godette-Greer, PhD qal6@cdc.gov

Email

qal6@cdc.gov

qal6@cdc.gov

Documents

File nameDescriptionLast updated
Foa_Content_of_RFA-DP-22-001_Amendment_2.pdf
Foa_Content_of_RFA-DP-22-001 Amendment 2.pdf
Jan 27, 2022 06:43 PM UTC
RFA-DP-22-001_Q_and_A_Final.pdf
RFA-DP-22-001 Q and A Final
Jan 19, 2022 08:04 PM UTC
Foa_Content_of_RFA-DP-22-001_Rev.pdf
Foa_Content_of_RFA-DP-22-001 Rev.pdf
Dec 20, 2021 07:08 PM UTC

Link to additional information

--

Archived: March 3, 2022

Application process

This site is a work in progress. Go to www.grants.gov to apply, track application status, and subscribe to updates.

Award

$16,000,000

Program Funding

6

Expected awards

$--

Award Minimum

$570,000

Award Maximum

Funding opportunity number:

RFA-DP-22-001

Cost sharing or matching requirement:

No

Funding instrument type:

Cooperative agreement

Opportunity Category:

Discretionary

Opportunity Category Explanation:

--

Category of Funding Activity:

Health

Category Explanation:

--

History

Version:

7

Posted date:

November 18, 2021

Archive date:

March 3, 2022

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov